Dysregulation of miR-106a and miR-591 Confers Paclitaxel Resistance to Ovarian Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2013.305
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Hypoxia-Induced Up-Regulation of miR-27a Promotes Paclitaxel Resistance in Ovarian Cancer

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2020English

Clinical Relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in Colorectal Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

miR-363 Confers Taxane Resistance in Ovarian Cancer by Targeting the Hippo Pathway Member, LATS2

Oncotarget
Oncology
2018English

Potential Roles of miR-106a in Breast Cancer

2011English

Downregulation of miR-194-5p Induces Paclitaxel Resistance in Ovarian Cancer Cells by Altering MDM2 Expression

Oncotarget
Oncology
2019English

SLC27A2 Regulates miR-411 to Affect Chemo-Resistance in Ovarian Cancer

Neoplasma
Cancer Research
2018English

Downregulation of miR‑200c‑3p Contributes to the Resistance of Breast Cancer Cells to Paclitaxel by Targeting SOX2

Oncology Reports
MedicineCancer ResearchOncology
2018English

Overexpression of miR‑106a Enhances Oxaliplatin Sensitivity of Colorectal Cancer Through Regulation of FOXQ1

Oncology Letters
Cancer ResearchOncology
2019English

Sialyltransferase ST3GAL1 Promotes Cell Migration, Invasion, and TGF-β1-induced EMT and Confers Paclitaxel Resistance in Ovarian Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy